PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy
Kaimin Xiao(Center for Life Sciences), Haidong Tang(Tsinghua University), Peng Qi(Shaoxing University), Xiyue Yao(Tsinghua University), Ian-Ian Ng(Tsinghua University), Y. Du(Fujian Medical University), Silin Zhang(State Key Laboratory of Respiratory Disease)
Cited by 30
Related Papers
Circulating long non-coding RNAs in cancer: current status and future perspectives
|Molecular Cancer|2016|312
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|bioRxiv (Cold Spring Harbor Laboratory)|2020|168
E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition
|Cancer Management and Research|2018|41
Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells
|Journal for ImmunoTherapy of Cancer|2024|16